Fungal Biofilm Culture
Materials Required
Principle
Fungal biofilm culture is an in vitro method for growing surface-attached fungal communities, most commonly Candida albicans, on abiotic substrates such as polystyrene wells, silicone elastomer, or polymethylmethacrylate; the assay models adhesion, proliferation, filamentation, extracellular-matrix-associated maturation, and dispersion[1][2][3]. Biofilm output can be read by optical density at 600 nm for adherent biomass, XTT reduction for metabolic activity, CFU recovery for viable attached or dispersed cells, and microscopy for architecture[1][2][4][5].
MCE has not independently verified the accuracy of these methods. They are for reference only.
Experimental Materials
• Use YPD agar or broth to recover and expand fungal cultures before biofilm inoculation; use RPMI medium or Spider medium for C. albicans biofilm development in microplate assays; use sterile 1× PBS to remove non-adherent or weakly adherent cells after the adherence phase[1][2].
• For metabolic biofilm quantification, use XTT with an electron-coupling reagent such as menadione when following the published Candida XTT biofilm format[4][5][6].
• XTT is used as a colorimetric metabolic readout because metabolically active sessile cells reduce tetrazolium salt to a measurable formazan product; crystal violet is an alternative biomass stain reported for Candida biofilm quantification, but XTT was reported as more reproducible, accurate, and efficient among seven tested Candida biofilm quantitation methods[4][5][6].
• Fluorescent staining may be used with confocal scanning laser microscopy when the experimental goal is biofilm architecture rather than a bulk plate-reader endpoint[3][1].
• Use flat-bottom, non-tissue-culture-treated 96-well or 384-well microplates for static high-throughput biofilm culture; use a shaking incubator set to 37°C for adherence and biofilm growth; use a plate reader for OD600 or XTT absorbance endpoints; use confocal microscopy, scanning electron microscopy, or microfluidic equipment only when the selected literature-supported readout requires those instruments[1][2][3][5].
• For metabolic biofilm quantification, use XTT with an electron-coupling reagent such as menadione when following the published Candida XTT biofilm format[4][5][6].
• XTT is used as a colorimetric metabolic readout because metabolically active sessile cells reduce tetrazolium salt to a measurable formazan product; crystal violet is an alternative biomass stain reported for Candida biofilm quantification, but XTT was reported as more reproducible, accurate, and efficient among seven tested Candida biofilm quantitation methods[4][5][6].
• Fluorescent staining may be used with confocal scanning laser microscopy when the experimental goal is biofilm architecture rather than a bulk plate-reader endpoint[3][1].
• Use flat-bottom, non-tissue-culture-treated 96-well or 384-well microplates for static high-throughput biofilm culture; use a shaking incubator set to 37°C for adherence and biofilm growth; use a plate reader for OD600 or XTT absorbance endpoints; use confocal microscopy, scanning electron microscopy, or microfluidic equipment only when the selected literature-supported readout requires those instruments[1][2][3][5].
Experimental Procedure
• Recover C. albicans on YPD agar at 30°C for 48 h, then grow overnight cultures in YPD at 30°C for 12-15 h on a roller drum or shaker at 250 rpm before preparing the biofilm inoculum[1].
• For the 96-well optical-density biofilm format, adjust cells to final OD600 0.5 in 200 µL RPMI or Spider medium per well; for the 384-well format, use 1 µL overnight culture in 90 µL medium, corresponding to final OD600 about 0.15 in the reported protocol[1].
• Seed cells into flat-bottom, non-tissue-culture-treated microplate wells, seal plates to reduce evaporation and cross-contamination, and incubate for adhesion at 37°C for 90 min with shaking at 250 rpm in 96-well plates or 350 rpm in 384-well plates[1].
• Remove medium, wash wells with 200 µL 1× PBS for 96-well plates or 50 µL 1× PBS for 384-well plates, add fresh medium at 200 µL for 96-well plates or 90 µL for 384-well plates, reseal, and incubate at 37°C for 24 h with the same shaking speed[1].
• For adhesion-specific measurement, after the 90-min adherence step wash wells twice with 200 µL PBS, resuspend adherent cells vigorously in water, serially dilute, plate on YPD agar, incubate for 2 days at 30°C, and quantify adherent cells by CFU counts[1].
• For mature-biofilm development studies, Candida biofilm development has been described across early adhesion, germination and microcolony formation, filamentation, monolayer development, proliferation, and maturation over 0-48 h, so 24 h and 48 h endpoints are literature-supported time points when the study question requires maturation assessment[7][3].
• For OD-based biofilm quantification, aspirate medium after growth and read OD600 using a standard plate reader; subtract the mean blank-well value from each experimental well, normalize each blank-subtracted value to the relevant control mean, calculate standard deviation, and perform statistical analysis such as an unpaired two-tailed Student’s t test with unequal variance when matching the reported assay format[1].
• The published 384-well OD assay used eight wells per condition, and the 96-well format used six wells per condition for standard biofilm OD analysis[1].
• For XTT analysis, interpret absorbance as a metabolic-activity readout rather than total biomass; this distinction matters because metabolic assays may miss metabolically inactive biofilm subpopulations, while OD or crystal violet-based assays primarily reflect attached biomass[1][5].
• Include blank wells, untreated wild-type or vehicle-treated controls, and condition-matched controls; when testing antifungal inhibition, the literature distinguishes adherence inhibition, developmental inhibition, sustained inhibition, and mature-biofilm disruption formats according to whether the compound is present during adhesion, biofilm growth, both phases, or after a 24-h established biofilm[1][4].
• For the 96-well optical-density biofilm format, adjust cells to final OD600 0.5 in 200 µL RPMI or Spider medium per well; for the 384-well format, use 1 µL overnight culture in 90 µL medium, corresponding to final OD600 about 0.15 in the reported protocol[1].
• Seed cells into flat-bottom, non-tissue-culture-treated microplate wells, seal plates to reduce evaporation and cross-contamination, and incubate for adhesion at 37°C for 90 min with shaking at 250 rpm in 96-well plates or 350 rpm in 384-well plates[1].
• Remove medium, wash wells with 200 µL 1× PBS for 96-well plates or 50 µL 1× PBS for 384-well plates, add fresh medium at 200 µL for 96-well plates or 90 µL for 384-well plates, reseal, and incubate at 37°C for 24 h with the same shaking speed[1].
• For adhesion-specific measurement, after the 90-min adherence step wash wells twice with 200 µL PBS, resuspend adherent cells vigorously in water, serially dilute, plate on YPD agar, incubate for 2 days at 30°C, and quantify adherent cells by CFU counts[1].
• For mature-biofilm development studies, Candida biofilm development has been described across early adhesion, germination and microcolony formation, filamentation, monolayer development, proliferation, and maturation over 0-48 h, so 24 h and 48 h endpoints are literature-supported time points when the study question requires maturation assessment[7][3].
• For OD-based biofilm quantification, aspirate medium after growth and read OD600 using a standard plate reader; subtract the mean blank-well value from each experimental well, normalize each blank-subtracted value to the relevant control mean, calculate standard deviation, and perform statistical analysis such as an unpaired two-tailed Student’s t test with unequal variance when matching the reported assay format[1].
• The published 384-well OD assay used eight wells per condition, and the 96-well format used six wells per condition for standard biofilm OD analysis[1].
• For XTT analysis, interpret absorbance as a metabolic-activity readout rather than total biomass; this distinction matters because metabolic assays may miss metabolically inactive biofilm subpopulations, while OD or crystal violet-based assays primarily reflect attached biomass[1][5].
• Include blank wells, untreated wild-type or vehicle-treated controls, and condition-matched controls; when testing antifungal inhibition, the literature distinguishes adherence inhibition, developmental inhibition, sustained inhibition, and mature-biofilm disruption formats according to whether the compound is present during adhesion, biofilm growth, both phases, or after a 24-h established biofilm[1][4].
Troubleshooting
Problem: Whole-well biofilm detaches during aspiration.
• Possible Cause: Mechanical disturbance during medium removal or addition.• Literature-supported Solution: Note and exclude fully detached outlier wells; for disruption assays, aspirate and replace medium cautiously, add fresh medium slowly to the side opposite the aspiration side, and process small groups of wells to avoid prolonged air exposure or desiccation[1].
Problem: OD or stain-based biomass does not match XTT metabolic activity.
• Possible Cause: OD, crystal violet, and XTT measure different biofilm properties, and XTT reflects metabolic activity rather than total attached biomass.• Literature-supported Solution: Select the endpoint according to the biological question, and use complementary readouts when biomass and viability/metabolism must be separated[1][5].
Problem: Subtle mutant or treatment phenotypes are not detected in RPMI.
• Possible Cause: RPMI produced thicker C. albicans biofilms than Spider medium in the optimized OD assay, which can obscure smaller phenotypic effects.• Literature-supported Solution: Use Spider medium when the goal is to detect subtle biofilm defects, while retaining RPMI when thicker biofilm formation is desired[1].
Problem: Results differ across Candida species or clinical materials.
• Possible Cause: Biofilm output varies by Candida species, strain, growth medium, inoculum, and substrate material.• Literature-supported Solution: Avoid direct cross-species or cross-material comparisons unless medium, inoculum, substrate, and readout are controlled within the experiment[1][8][9].
References:
- [1]. Lohse MB, et al. Assessment and optimizations of Candida albicans in vitro biofilm assays. Antimicrob Agents Chemother. 2017;61(5):e02749-16. [Content Brief]
- [2]. Gulati M, Lohse MB, Ennis CL, Gonzalez RE, Perry AM, Bapat P, et al. In vitro culturing and screening of Candida albicans biofilms. Curr Protoc Microbiol. 2018;50(1):e60. [Content Brief]
- [3]. Chandra J, et al. Biofilm formation by the fungal pathogen Candida albicans: development, architecture, and drug resistance. J Bacteriol. 2001;183(18):5385-5394. [Content Brief]
- [4]. Ramage G, et al. Standardized method for in vitro antifungal susceptibility testing of Candida albicans biofilms. Antimicrob Agents Chemother. 2001;45(9):2475-2479. [Content Brief]
- [5]. Taff HT, et al. Comparative analysis of Candida biofilm quantitation assays. Med Mycol. 2012;50(2):214-218. [Content Brief]
- [6]. Roehm NW, et al. An improved colorimetric assay for cell proliferation and viability utilizing the tetrazolium salt XTT. J Immunol Methods. 1991;142(2):257-265. [Content Brief]
- [7]. Ramage G, et al. Characteristics of biofilm formation by Candida albicans. Rev Iberoam Micol. 2001;18(4):163-170. [Content Brief]
- [8]. Silva S, et al. In vitro biofilm activity of non-Candida albicans Candida species. Curr Microbiol. 2010;61(6):534-540. [Content Brief]
- [9]. Estivill D, et al. Biofilm formation by five species of Candida on three clinical materials. J Microbiol Methods. 2011;86(2):238-242. [Content Brief]
LinkedIn
Researchgate
Instagram
X
Facebook
WhatsApp
Reddit
Mail